Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
MEDP	MEDPACE HOLDINGS INC	$13.96B	67.70%	21.90%	136.65%	-206.60%	8.12	0.43	31.60%	18.70%	21.51%
RMD	RESMED INC	$39.63B	25.20%	18.20%	23.92%	47.80%	0.36	3.41	58.80%	26.20%	31.56%
AMGN	AMGEN INC	$146.96B	97.90%	7.40%	15.37%	14.40%	10.83	1.31	64.50%	19.00%	29.68%
ELV	ELEVANCE HEALTH INC	$71.74B	12.50%	4.50%	10.76%	14.30%	1.79	1.45	15.50%	2.80%	4.44%
TMO	THERMO FISHER SCIENTIFIC INC	$175.30B	13.30%	6.60%	9.49%	15.70%	1.01	1.93	41.20%	15.20%	19.44%
SYK	STRYKER CORP	$141.08B	14.10%	6.50%	8.58%	12.50%	1.19	1.78	64.10%	12.30%	14.07%
FLGT	FULGENT GENETICS INC	$691.46M	-4.50%	-4.20%	-5.21%	-6.40%	0.08	6.01	40.00%	-16.80%	-19.39%
JAZZ	JAZZ PHARMACEUTICALS PLC	$7.70B	-10.00%	-3.50%	-3.40%	-4.00%	1.95	1.62	88.70%	-9.90%	-7.37%
STXS	STEREOTAXIS INC	$266.52M	-464.20%	-53.40%	-114.34%	-270.60%	23.64	1.06	50.20%	-77.50%	-73.43%
HCAT	HEALTH CATALYST INC	$197.05M	-27.70%	-12.60%	-17.10%	-35.30%	0.77	1.83	45.30%	-31.70%	-27.98%
PLX	PROTALIX BIOTHERAPEUTICS INC	$164.25M	14.70%	8.70%	16.88%	29.10%	0.57	2.72	57.50%	10.10%	14.82%
EXEL	EXELIXIS INC	$10.51B	27.70%	21.10%	33.12%	32.40%	0.32	3.51	96.60%	27.00%	34.78%
IQV	IQVIA HOLDINGS INC	$30.53B	20.00%	4.50%	10.54%	16.60%	3.95	0.84	34.20%	7.90%	14.13%
EVAX	EVAXION A	$25.52M	-320.20%	-63.60%	-59.92%	-74.40%	2.61	3.42	100.00%	-377.00%	-323.11%
HUM	HUMANA INC	$30.66B	9.00%	3.20%	8.30%	8.80%	1.76	1.95	15.00%	1.30%	2.23%
ASMB	ASSEMBLY BIOSCIENCES INC	$189.27M	-149.00%	-39.00%	-116.58%	-139.30%	3.46	1.64	N/A	N/A	N/A
PTCT	PTC THERAPEUTICS INC	$4.68B	-71.70%	29.30%	39.40%	123.50%	-15.30	3.89	96.90%	33.60%	45.78%
JYNT	JOINT CORP	$151.44M	-10.20%	-2.70%	-6.41%	-18.30%	2.15	1.80	36.80%	-11.30%	-13.02%
ILMN	ILLUMINA INC	$14.09B	55.20%	20.50%	32.56%	30.50%	1.70	1.81	66.50%	29.40%	35.15%
ACAD	ACADIA PHARMACEUTICALS INC	$3.52B	35.30%	21.70%	31.92%	64.00%	0.48	2.88	92.00%	23.00%	26.58%
SPRO	SPERO THERAPEUTICS INC	$106.36M	-120.30%	-55.60%	-113.62%	-424.60%	0.89	3.98	100.00%	-110.30%	-110.34%
APLS	APELLIS PHARMACEUTICALS INC	$2.83B	-116.10%	-26.70%	-29.03%	-24.10%	4.26	3.77	83.80%	-30.20%	-23.88%
WAT	WATERS CORP	$17.36B	35.00%	14.40%	23.24%	27.50%	1.18	1.75	59.00%	21.70%	28.24%
SRDX	SURMODICS INC	$428.12M	-17.30%	-11.60%	-7.42%	-12.70%	0.48	5.14	73.40%	-16.30%	-9.11%
XGN	EXAGEN INC	$239.62M	-136.30%	-36.30%	-29.17%	-37.60%	1.79	4.95	59.40%	-28.80%	-24.02%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$193.51M	N/A	N/A	N/A	N/A	-1.25	0.11	N/A	N/A	N/A
BLCO	BAUSCH & LOMB CORP	$5.13B	-4.20%	-2.00%	0.13%	0.20%	1.14	1.55	59.70%	-5.60%	0.31%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$2.01B	-60.90%	-23.00%	-27.07%	-22.50%	1.76	2.84	66.00%	-59.10%	-53.35%
IRD	OPUS GENETICS INC	$109.03M	-366.70%	-142.10%	-315.46%	614.70%	1.21	1.90	100.00%	-377.90%	-377.89%
INBX	INHIBRX BIOSCIENCES INC	$473.38M	-137.80%	-76.30%	-91.16%	-390.10%	2.09	4.98	100.00%	-11,692.40%	-11,275.86%
MTD	METTLER TOLEDO INTERNATIONAL INC	$24.81B	-459.70%	25.20%	47.70%	33.80%	-14.14	1.12	59.90%	21.50%	28.29%
CYH	COMMUNITY HEALTH SYSTEMS INC	$445.58M	N/A	-1.40%	7.60%	4.40%	-9.04	1.59	84.70%	-1.50%	6.82%
SEM	SELECT MEDICAL HOLDINGS CORP	$1.57B	7.80%	2.20%	5.13%	4.40%	2.25	1.15	9.60%	3.20%	5.69%
CON	CONCENTRA GROUP HOLDINGS PARENT INC	$2.67B	29.70%	6.20%	12.42%	12.80%	7.81	1.10	28.00%	8.10%	15.48%
OGN	ORGANON & CO	$2.65B	125.00%	5.30%	11.01%	9.30%	17.42	1.65	56.30%	11.10%	18.77%
ASTH	ASTRANA HEALTH INC	$1.66B	4.90%	2.70%	9.79%	15.70%	1.09	1.70	11.90%	1.60%	4.22%
RGEN	REPLIGEN CORP	$7.06B	-1.20%	-0.80%	-0.07%	-0.10%	0.44	6.79	44.40%	-3.50%	-0.28%
TDOC	TELADOC HEALTH INC	$1.44B	-14.20%	-6.20%	-8.41%	-18.00%	1.04	2.67	70.30%	-8.20%	-8.25%
RCUS	ARCUS BIOSCIENCES INC	$1.37B	-56.00%	-25.70%	-33.64%	-35.90%	0.96	4.51	100.00%	-113.70%	-111.07%
CTOR	CITIUS ONCOLOGY INC	$156.74M	-68.40%	-29.70%	-65.81%	-52.40%	1.83	0.35	N/A	N/A	N/A
BNTX	BIONTECH SE	$23.58B	-1.80%	-1.60%	-1.65%	-3.50%	0.17	8.61	79.80%	-12.00%	-11.35%
RDNT	RADNET INC	$5.84B	-1.60%	-0.40%	2.02%	2.00%	2.51	2.00	11.60%	-0.80%	3.14%
CERT	CERTARA INC	$1.90B	0.70%	0.50%	2.20%	9.70%	0.44	2.16	61.10%	2.00%	7.67%
IMCR	IMMUNOCORE HOLDINGS PLC	$1.71B	-5.90%	-2.10%	-0.47%	-0.50%	1.72	6.36	99.00%	-6.50%	-1.24%
SEER	SEER INC	$127.89M	-25.90%	-23.20%	-26.45%	-25.40%	0.12	19.15	49.90%	-506.20%	-504.64%
KRYS	KRYSTAL BIOTECH INC	$4.86B	15.20%	13.80%	16.05%	26.50%	0.09	9.68	93.40%	40.80%	46.98%
MYGN	MYRIAD GENETICS INC	$716.44M	-62.60%	-41.70%	-87.24%	-115.90%	0.75	1.42	70.40%	-47.40%	-50.01%
ATR	APTARGROUP INC	$8.72B	15.30%	8.50%	15.42%	21.90%	0.80	1.22	38.30%	10.80%	14.93%
PSTV	PLUS THERAPEUTICS INC	$61.54M	N/A	-211.30%	-504.28%	315.60%	2.41	1.26	100.00%	-357.90%	-287.76%
VCEL	VERICEL CORP	$1.53B	2.50%	1.70%	2.00%	2.00%	0.42	4.97	73.50%	2.90%	3.16%
TWST	TWIST BIOSCIENCE CORP	$1.62B	-18.40%	-13.80%	-15.21%	-26.50%	0.35	3.90	49.20%	-23.50%	-23.36%
EBS	EMERGENT BIOSOLUTIONS INC	$483.62M	-27.30%	-9.10%	-0.07%	-0.10%	1.58	6.32	35.20%	-13.60%	-0.09%
TALK	TALKSPACE INC	$465.56M	2.50%	2.10%	-1.93%	-5.60%	0.18	6.51	44.30%	1.40%	-1.09%
MDGL	MADRIGAL PHARMACEUTICALS INC	$9.46B	-38.40%	-27.30%	-32.75%	-34.00%	0.46	5.11	96.30%	-54.70%	-52.01%
MRK	MERCK & CO INC	$196.23B	34.90%	14.00%	22.33%	26.50%	1.40	1.42	76.60%	25.80%	32.11%
PHG	KONINKLIJKE PHILIPS NV	$24.81B	-5.80%	-2.40%	3.11%	4.90%	1.41	1.23	43.10%	-3.90%	3.60%
HOLX	HOLOGIC INC	$14.95B	11.50%	6.30%	10.15%	18.50%	0.82	3.56	51.80%	13.80%	19.71%
SCLX	SCILEX HOLDING CO	$203.18M	N/A	-138.10%	32.94%	40.80%	-1.34	0.11	70.40%	-278.00%	-165.46%
DERM	JOURNEY MEDICAL CORP	$172.11M	-48.70%	-11.30%	-12.78%	-32.50%	3.22	1.27	69.40%	-15.50%	-9.22%
INGN	INOGEN INC	$222.27M	-13.80%	-8.50%	-10.91%	-27.00%	0.56	3.03	45.20%	-7.60%	-7.78%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$86.79M	4.10%	2.30%	4.56%	4.10%	0.50	1.31	49.00%	6.10%	8.73%
ENTA	ENANTA PHARMACEUTICALS INC	$168.89M	-89.00%	-27.30%	-33.61%	-29.90%	2.80	5.00	100.00%	-142.00%	-133.00%
GYRE	GYRE THERAPEUTICS INC	$689.60M	5.80%	3.10%	5.16%	7.40%	0.25	5.40	95.90%	4.10%	6.85%
ABEO	ABEONA THERAPEUTICS INC	$278.96M	77.70%	39.80%	36.32%	85.00%	0.51	6.73	100.00%	14,310.50%	19,223.25%
UTMD	UTAH MEDICAL PRODUCTS INC	$201.35M	10.50%	10.10%	13.06%	77.90%	0.03	41.87	57.30%	32.30%	39.89%
ACHC	ACADIA HEALTHCARE COMPANY INC	$2.27B	4.60%	2.30%	5.39%	5.90%	1.00	1.32	34.80%	4.30%	9.65%
AMN	AMN HEALTHCARE SERVICES INC	$722.43M	-20.70%	-6.50%	-7.18%	-8.10%	2.35	1.08	30.10%	-5.80%	-4.56%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$193.33M	4.70%	3.50%	3.19%	5.20%	0.25	9.24	100.00%	7.30%	7.27%
TARS	TARSUS PHARMACEUTICALS INC	$2.38B	-32.40%	-21.00%	-20.45%	-29.10%	0.49	5.26	93.40%	-31.10%	-28.01%
BAX	BAXTER INTERNATIONAL INC	$11.29B	-2.10%	-0.70%	0.35%	0.30%	1.88	2.30	35.30%	-1.40%	0.58%
SRPT	SAREPTA THERAPEUTICS INC	$1.79B	-4.40%	-1.60%	-0.87%	-0.60%	1.71	2.89	79.30%	-2.30%	-0.97%
ALVO	ALVOTECH	$2.60B	-20.60%	5.00%	11.81%	6.20%	-9.04	1.82	53.90%	11.30%	23.38%
LFCR	LIFECORE BIOMEDICAL INC	$259.55M	-788.60%	-19.90%	-10.94%	-7.10%	85.36	2.71	33.40%	-37.90%	-17.34%
PTHS	PELTHOS THERAPEUTICS INC	$102.82M	N/A	-689.50%	131.48%	454.90%	-1.13	0.11	N/A	N/A	N/A
CERS	CERUS CORP	$276.05M	-34.20%	-9.30%	-7.75%	-4.70%	2.83	2.00	60.90%	-8.70%	-4.61%
HROW	HARROW INC	$1.74B	-17.50%	-2.80%	14.70%	7.70%	5.96	0.62	74.60%	-4.50%	6.21%
NVO	NOVO NORDISK A S	$248.30B	77.90%	24.20%	51.26%	67.90%	1.87	0.78	83.90%	35.60%	45.13%
PRE	PRENETICS GLOBAL LTD	$166.52M	-30.10%	-23.40%	-32.33%	-54.30%	0.32	2.02	41.60%	-98.60%	-113.43%
IRTC	IRHYTHM TECHNOLOGIES INC	$5.49B	-104.70%	-9.90%	-9.43%	-6.90%	8.30	5.02	69.80%	-14.10%	-11.93%
AXSM	AXSOME THERAPEUTICS INC	$5.83B	-357.60%	-41.70%	-80.39%	-140.30%	7.76	1.57	91.50%	-49.90%	-48.34%
CVAC	CUREVAC NV	$1.21B	29.20%	25.10%	35.70%	90.50%	0.18	6.17	94.80%	37.90%	43.41%
EUDA	EUDA HEALTH HOLDINGS LTD	$63.16M	N/A	-1,021.00%	626.82%	513.40%	-1.67	0.18	19.00%	-382.90%	-381.87%
ALGN	ALIGN TECHNOLOGY INC	$9.15B	11.30%	7.00%	14.70%	22.50%	0.59	1.23	69.80%	11.00%	15.65%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.27B	19.40%	9.10%	14.07%	15.90%	1.17	2.95	50.50%	19.40%	27.48%
PACS	PACS GROUP INC	$2.13B	N/A	N/A	N/A	N/A	5.80	1.71	N/A	N/A	N/A
VRCA	VERRICA PHARMACEUTICALS INC	$39.48M	N/A	-115.50%	-400.01%	-132.00%	-3.24	1.26	86.50%	-330.50%	-268.91%
NEO	NEOGENOMICS INC	$1.02B	-11.70%	-6.60%	-7.70%	-13.80%	0.63	3.92	43.90%	-15.10%	-14.46%
ENSG	ENSIGN GROUP INC	$9.95B	17.20%	6.80%	10.33%	7.80%	1.44	1.41	15.90%	7.00%	9.35%
AMWL	AMERICAN WELL CORP	$100.14M	-40.90%	-28.80%	-41.00%	-1,817.90%	0.33	3.30	49.00%	-46.20%	-45.70%
TKNO	ALPHA TEKNOVA INC	$324.39M	-28.50%	-19.70%	-21.17%	-19.10%	0.45	5.64	21.00%	-60.90%	-59.19%
OKYO	OKYO PHARMA LTD	$81.99M	N/A	-180.40%	127.79%	102.70%	-1.66	0.40	N/A	N/A	N/A
SLP	SIMULATIONS PLUS INC	$299.69M	-37.10%	-34.70%	-55.87%	-274.70%	0.09	5.11	53.70%	-78.60%	-86.34%
GKOS	GLAUKOS CORP	$4.58B	-12.50%	-9.60%	-9.54%	-15.70%	0.29	5.51	76.30%	-21.40%	-20.00%
TECH	BIO-TECHNE CORP	$8.07B	3.60%	2.80%	4.49%	8.10%	0.33	3.46	64.80%	6.00%	8.77%
WEAV	WEAVE COMMUNICATIONS INC	$548.50M	-42.50%	-15.60%	-23.81%	-26.10%	1.59	1.22	71.80%	-13.60%	-13.27%
BGM	BGM GROUP LTD	$73.42M	-2.40%	-2.10%	-3.78%	-20.90%	0.13	1.82	19.40%	-10.10%	-25.89%
LMAT	LEMAITRE VASCULAR INC	$1.91B	13.70%	9.10%	11.65%	12.60%	0.59	13.96	69.10%	20.10%	27.14%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$4.53B	-46.00%	-12.50%	-5.81%	-4.80%	1.30	5.15	100.00%	-26.40%	-14.41%
MESO	MESOBLAST LTD	$2.03B	-19.00%	-14.10%	-11.56%	-103.10%	0.31	1.99	70.20%	-593.90%	-458.45%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$3.11B	12.20%	6.40%	10.07%	23.80%	0.85	4.21	55.80%	18.90%	29.16%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	634	+1.79%	+1.91%	+6.43%	-34.10%	-103.63x	4.74x	-110.35%	-7.14%	-11.38%	+74.80%	Strong Buy
Diagnostics & Research	56	+1.01%	-2.91%	-2.11%	-20.34%	20.19x	3.68x	-3.05%	+7.21%	+15.74%	+12.47%	Strong Buy
Drug Manufacturers - General	19	+1.12%	-2.43%	-1.22%	-11.24%	36.82x	5.90x	+60.33%	+10.39%	+17.87%	+44.86%	Buy
Drug Manufacturers - Specialty & Generic	76	+0.80%	-1.60%	+0.72%	-14.92%	-26.18x	2.19x	+11.47%	+4.52%	+9.99%	+34.64%	Buy
Healthcare Plans	11	+0.51%	+2.09%	+1.67%	-31.43%	14.69x	2.04x	+15.83%	+4.97%	+11.53%	+16.07%	Buy
Health Information Services	53	+1.70%	-0.25%	-0.80%	-51.95%	79.61x	4.19x	+8.45%	+5.32%	+9.21%	+27.22%	Strong Buy
Medical Care Facilities	47	+1.83%	+4.11%	+3.99%	-27.10%	16.54x	5.02x	-187.08%	+6.89%	+15.30%	+13.48%	Buy
Medical Devices	142	+0.34%	-2.25%	-5.08%	-29.83%	30.11x	3.93x	+13.92%	+8.58%	+10.09%	+31.97%	Strong Buy
Medical Distribution	10	+2.95%	+6.64%	+8.45%	+42.42%	28.76x	311.71x	-10.64%	+3.09%	+19.03%	+11.15%	Buy
Medical Instruments & Supplies	55	+1.38%	-1.61%	-4.20%	-63.95%	29.83x	3.29x	+10.52%	+8.43%	+11.16%	+28.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: B.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 74.57% over the past year, overperforming other healthcare stocks by 108 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 82.42% from Theravance Biopharma's current stock price of $14.07.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -4.34% over the past year, overperforming other healthcare stocks by 29 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 33.09% from Embecta's current stock price of $13.90.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Infusystem Holdings (NYSEMKT:INFU)

Infusystem Holdings (NYSEMKT:INFU) is the #3 top healthcare stock out of 1103 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Infusystem Holdings (NYSEMKT:INFU) is: Value: C, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Infusystem Holdings (NYSEMKT:INFU) has a Due Diligence Score of 29, which is 4 points higher than the healthcare sector average of 25. It passed 9 out of 33 due diligence checks and has average fundamentals. Infusystem Holdings has seen its stock return 57.62% over the past year, overperforming other healthcare stocks by 91 percentage points.

Infusystem Holdings has an average 1 year price target of $13.50, an upside of 30.56% from Infusystem Holdings's current stock price of $10.34.

Infusystem Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Infusystem Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.55%, which is 12 percentage points higher than the healthcare sector average of 2.08%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 8.33%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Cryo Cell International's dividend payout ratio of -2,166.7% indicates that its high dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 7.89%, which is 6 percentage points higher than the healthcare sector average of 2.08%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 1.36% in the last day, and up 0.15% over the last week. Bioaffinity Technologies was the among the top gainers in the healthcare sector, gaining 55.13% yesterday.

bioAffinity Technologies shares are trading lower after the company priced a $4.8M public offering of ~1.92M shares or pre-funded warrants at $2.50 per share.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -30.86% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -4.34% in the past year. It has overperformed other stocks in the healthcare sector by 29 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 89.06% in the past year. It has overperformed other stocks in the healthcare sector by 122 percentage points.

Are healthcare stocks a good buy now?

52.17% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.4% over the next year.

5.3% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.13% of healthcare stocks are rated B (Buy), 46.64% are rated C (Hold), 24.62% are rated D (Sell), and 11.31% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Embecta (NASDAQ:EMBC)

3. Infusystem Holdings (NYSEMKT:INFU)

1. Select Medical Holdings (NYSE:SEM)

2. Cryo Cell International (NYSEMKT:CCEL)

3. Dominari Holdings (NASDAQ:DOMH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.